"The progression of your ultrasound reports from 2025 to 2026 is actually quite reassuring. While the number and size of the lumps (fibroadenomas) may appear slightly increased, the fact that most have been downgraded from BIRADS 3 (Probably Benign) to BIRADS 2 (Benign) is a very positive clinical sign. Fibroadenomas and fibroadenosis are highly sensitive to hormonal fluctuations. Since there is no lymphadenopathy or ductal dilatation, these findings strongly suggest a benign condition related to hormonal cycles rather than any suspicious malignancy
Next Steps
Continued Surveillance: "Since one lesion remains categorized as BIRADS 3, a follow-up ultrasound in 6 months is the standard protocol to monitor for any significant changes in morphology or rapid growth."
Clinical Correlation: "I recommend a physical breast examination by a Surgical Oncologist or a Breast Specialist. They can correlate the ultrasound findings with the physical 'feel' of the lumps to determine if a fine-needle aspiration (FNAC) or biopsy is truly necessary."
Pain Management: "For the bilateral breast pain (mastalgia), your doctor may suggest evening primrose oil or specific
vitamin supplements to help regulate the hormonal response in the breast tissue."
Consultation: "To review the exact measurements from both years and discuss whether a baseline biopsy is needed for your peace of mind, please book a full consultation session via my Practo profile."
Health Tips
Hormonal breast changes are very common, and your 'Benign' downgrade is a great sign. Please book a full session to discuss your long-term monitoring plan.